|
|
| A B C D E F G H I J K L M N O P Q R S T U V W X Y Z # |
Enterovirus Panel, CF, Serum
Test Code12671
CPT Codes
86658 (x11)
Includes
Coxsackie A Antibodies, Serum
Echovirus Antibody Panel
Echovirus Antibody Panel
Preferred Specimen
6 mL serum
Minimum Volume
2 mL
Transport Container
Transport tube
Transport Temperature
Room temperature
Specimen Stability
Room temperature: 7 days
Refrigerated: 14 days
Frozen: 30 days
Refrigerated: 14 days
Frozen: 30 days
Reject Criteria (Eg, hemolysis? Lipemia? Thaw/Other?)
Gross hemolysis • Grossly lipemic • Grossly icteric
Methodology
Complement Fixation (CF)
FDA Status
This test was developed and its analytical performance characteristics have been determined by Quest Diagnostics. It has not been cleared or approved by the U.S. Food and Drug Administration. This assay has been validated pursuant to the CLIA regulations and is used for clinical purposes.
Setup Schedule
Set up and Report available: See individual assays
Reference Range
Coxsackie A Antibodies, Serum
Echovirus Antibody Panel
| Coxsackie A2 Ab | <1:8 titer |
| Coxsackie A4 Ab | <1:8 titer |
| Coxsackie A7 Ab | <1:8 titer |
| Coxsackie A9 Ab | <1:8 titer |
| Coxsackie A10 Ab | <1:8 titer |
| Coxsackie A16 Ab | <1:8 titer |
Echovirus Antibody Panel
| Echovirus 4 Ab | <1:8 titer |
| Echovirus 7 Ab | <1:8 titer |
| Echovirus 9 Ab | <1:8 titer |
| Echovirus 11 Ab | <1:8 titer |
| Echovirus 30 Ab | <1:8 titer |
Clinical Significance
Detectable titers to enteroviruses, particularly titers >1:32, typically indicate recent infection. Although there is considerable cross-reactivity among enteroviruses, the highest titer is usually associated with the infecting serotype.
